Product Recalls in Wyoming

Product recalls affecting Wyoming — including food, drugs, consumer products, medical devices, and vehicles distributed to Wyoming. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,547 recalls have been distributed to Wyoming in the last 12 months.

48,219 total recalls
2,547 in last 12 months

Showing 61616180 of 13,375 recalls

DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/160 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/320 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 10 mg/320 mg (a) 30-count bottles Recalled...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: infants* IBUPROFEN Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: fas.TRACT Coagulative Hemostatic Gel Recalled by CAO Group, Inc. Due to cGMP...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: SHEER DesenZ Desensitizing Treatment Recalled by CAO Group, Inc. Due to cGMP...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: FastStat Topical Hemostat Introductory Kit Recalled by CAO Group, Inc. Due...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: BeeGentle Honey Flavored Topical Anesthetic Recalled by CAO Group, Inc. Due...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 15, 2018· Fresenius Kabi USA, LLC

Recalled Item: SODIUM CHLORIDE INJECTION Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 15, 2018· Fresenius Kabi USA, LLC

Recalled Item: SODIUM CHLORIDE INJECTION Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 14, 2018· Ascend Laboratories LLC

Recalled Item: Quetiapine Tablets USP 400 mg Recalled by Ascend Laboratories LLC Due to...

The Issue: Presence of Foreign Substance; metal shard found in tablet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 9, 2018· AMERICAN HEALTH PACKAGING

Recalled Item: Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals) Recalled by AMERICAN...

The Issue: Cross contamination with other products: This sub-recall is being initiated...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 9, 2018· Ecolab Inc

Recalled Item: Medi-Stat Foam Recalled by Ecolab Inc Due to Labeling: Label mix-up - the...

The Issue: Labeling: Label mix-up - the label on the product may not match the formula...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 9, 2018· Ecolab Inc

Recalled Item: Equi-Soft Foam Recalled by Ecolab Inc Due to Labeling: Label mix-up - the...

The Issue: Labeling: Label mix-up - the label on the product may not match the formula...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 7, 2018· Dr. Reddy's Laboratories, Inc.

Recalled Item: Clopidogrel Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to Failed...

The Issue: Failed Dissolution Specification: Out-of-Specification results were observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund